Along with some of the best companies in the world, Medable is proud to join CancerX as a founding member. This alliance is co-hosted by the Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH).
Together, this group from both the public and private sectors will work on a shared goal to progress the White House’s Cancer Moonshot, which includes fostering a large community of patients, advocates, researchers, and clinicians who look to halve the cancer death rate within 25 years.
Beating cancer demands bold innovation and deliberate collaboration. CancerX is creating a dynamic ecosystem where ideas can flourish, expertise and resources can be shared, and innovative solutions can be rapidly developed and equitably deployed in the fight against cancer. As a co-host, we take immense pride in the diverse and inclusive community of pioneers coming together as members, all driven by a shared commitment to advancing the goals of the Cancer Moonshot. Together, we will advance the frontiers of cancer research and treatment through digital innovation, while striving to reduce the incidence and burden of cancer for all people. Santosh Mohan, Vice President, Digital, Moffitt Cancer Center
On May 25, CancerX released its first set of abstracts and reports. The first abstract outlined the alliance’s goals towards creating and aligning best practices and incentives, coordinating research, resources, future opportunities, and demonstrating success in oncology.
Multi-stakeholder collaboration is critical to harness the potential of digital innovation in the fight against cancer, and we're honored to partner with Medable to achieve the ambitious goals of CancerX," said Smit Patel, Associate Program Director at DiMe. "Through this impressive collaboration, we will establish best practices, build capacity, and demonstrate the impact of innovation on the life of every person on a cancer journey. Smit Patel, Associate Program Director at DiMe
The second abstract defined the value of digital innovation and technology in cancer treatment and addresses “methodological and implementation gaps” to help develop best practices for “equitable adoption of digital health technologies at scale in precision oncology.”
You can find them here:
- “CancerX: A national public-private partnership to boost innovation in the fight against cancer,”
- “Advancing digital innovation to improve equity and reduce financial toxicity in cancer treatment,”
CancerX also recently released the details surrounding its inaugural project, which focuses on assessing, quantifying, and improving the impact of technology and digital solutions in oncology care. It can be read here.
- “Advancing Digital Innovation to Improve Equity and Reduce Financial Toxicity in Cancer Care and Research.”
To learn more about CancerX, click here.
CancerX alliance members